天美传媒

Robert Siegel is a Lecturer in Management and has led primary research and written cases on Google, Charles Schwab, Daimler, AB InBev, Box, Stripe, Target, AngelList, 23andMe, C3.ai, Majid Al Futtaim, Tableau, PayPal, SurveyMonkey, Medium, Autodesk, Minted, Zuora, Axel Springer and Michelin, amongst others.

He is also a General Partner at XSeed Capital and a Venture Partner at Piva. He sits on the Board of Directors of Foxeye Robotics and Avochato. He led investments in Sparta Science, Zooz (acquired by PayU of Naspers - NPN), Hive, Lex Machina (acquired by LexisNexis of the RELX Group - RELX), CirroSecure (acquired by Palo Alto Networks - PANW), Nova Credit, Disco, The League, Trove, Teapot (acquired by Stripe), Smart Coffee Technology, Pixlee and SIPX (acquired by ProQuest). He also supports other companies such as Citrine Informatics.

Robert is a Member of the Supervisory Board of TTTech Auto AG, and is Chairman of the Strategic Advisory Board for TTTech Computertechnik AG in Vienna, Austria. He is a Member of the Industry Advisory Boards for HERE Technologies and Tulco, and is the Co-President Emeritus of Stanford Angels & Entrepreneurs, an alumni association that fosters relationships to strengthen the Stanford startup community. Robert was on the Board of SmartDrive Systems for 14 years (acquired by Omnitracs), has co-authored several articles for the Harvard Business Review, California Management Review, is a Wall Street Journal Startup Guru, and is a frequent contributor to Fortune, TechCrunch, VentureBeat and Forbes.

Robert was previously General Manager of the Video and Software Solutions division for GE Security, with annual revenues of $350 million. He was also Executive Vice President of Pixim, Inc., a fabless semiconductor firm specializing in image sensors and processors (acquired by Sony). Before Pixim, Robert was Co-Founder & Chief Executive Officer of Weave Innovations Inc. (acquired by Kodak), a network services developer that invented the world鈥檚 first digital picture frame, and delivered photos and other digital media to PCs and internet / mobile devices.

Robert served in various management roles at Intel Corporation, including an executive position on their Corporate Business Development team, in which he invested capital in startups that were strategically aligned with Intel鈥檚 vision. 

Robert is the co-inventor of four patents and served as lead researcher for Andy Grove鈥檚 best-selling book, Only the Paranoid Survive.

Robert holds a BA from UC Berkeley and an MBA from Stanford University.  He is married with three children.

Benjamin F. Jones is the Gordon and Llura Gund Family Professor of Entrepreneurship, a Professor of Strategy, and the faculty director of the Kellogg Innovation and Entrepreneurship Initiative. An economist by training, Professor Jones studies the sources of economic growth in advanced economies, with an emphasis on innovation, entrepreneurship, and scientific progress.  He also studies global economic development, including the roles of education, climate, and national leadership in explaining the wealth and poverty of nations.  His research has appeared in journals such as Science, the Quarterly Journal of Economics and the American Economic Review, and has been profiled in media outlets such as the Wall Street Journal, the Economist, and The New Yorker.
A former Rhodes Scholar, Professor Jones served in 2010-2011 as the senior economist for macroeconomics for the White House Council of Economic Advisers and earlier served in the U.S. Department of the Treasury.   
Professor Jones is a non-resident senior fellow of the Brookings Institution, a research associate of the National Bureau of Economic Research, and a member of the Council on Foreign Relations.

Professor Garthwaite is the Herman R. Smith Research Professor in Hospital and Health Services, a Professor of Strategy, and the Director of the Program on Healthcare at Kellogg (HCAK). He is an applied economist whose research examines the business of healthcare with a focus on the interaction between private firms and public policies.

His recent work in the payer and provider sectors has focused on the private sector effects of the Affordable Care Act, the impact and operation of Medicaid Managed Care plans, the responses of non-profit hospitals to financial shocks, and the economic effects of expanded social insurance programs such as Medicaid and Medicare for All. 

Professor Garthwaite also studies questions of pricing and innovation in the biopharmaceutical sector. In this area he has examined the effect of changes in market size of investments in new product development, the evolving world of precision medicine, expanded patent protection on pricing in the Indian pharmaceutical market, the innovation response of United States pharmaceutical firms to increases in demand, and the relationship between health insurance expansions and high drug prices. 

His research has appeared in journals such as the Quarterly Journal of Economics, the American Economic Review, the Annals of Internal Medicine, and the New England Journal of Medicine.  In addition, he is a frequent media commentator appearing in media outlets such as the Wall Street Journal, the Washington Post, and The New York Times. He has also appeared as a guest on various television and radio shows such as Nightly Business Report and NPR Marketplace. In 2015, Professor Garthwaite was named one of Poet and Quants 40 Best under 40 Business School Professors.   

Garthwaite received a B.A. and a Masters in Public Policy from the University of Michigan and his PhD in Economics from the University of Maryland. Prior to receiving his PhD, he served in a variety of public policy positions including the Director of Research for the Employment Policies Institute. He has testified before the United States Senate, United States House of Representatives and state legislatures on matters related to the healthcare markets, prescription drugs, the minimum wage, and health care reforms.

Business strategy professor Henri Schildt, of Aalto University in Finland, researches the impact of data, digitalization, and artificial intelligence on companies. He is currently leading a 3-year research project studying how companies use generative artificial intelligence to redesign their processes and services. 

Bruce (he/him) is the founder and president of , an international network of organizations working to advance alternative proteins to help meet global climate, public health, food security, and biodiversity goals. Bruce is one of the leading global experts on alternative proteins, and currently oversees GFI’s global strategy, working with teams across Asia Pacific, Brazil, Europe, India, Israel, and the U.S. Bruce is an expert on food innovation, especially when it comes to feeding a growing population (with a growing demand for protein), in ways that are sustainble and equitable. Bruce is a TED Fellow, Y Combinator alum, 2021 “American Food Hero” (), and has penned op-eds for the Wall Street Journal, Foreign Policy, CNN, Nature Food, Los Angeles Times, Wired. He has also represented GFI on the TED Radio Hour, New Yorker Radio Hour, Ezra Klein Show, and Making Sense (Sam Harris). Bruce’s  has been viewed 2.4 million times and translated into 30 languages. He graduated magna cum laude from Georgetown Law and also holds degrees from Johns Hopkins University and the London School of Economics.